GABRR3 Gene

GABRR3 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GABRR3 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GABRR3</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>GABA-A Receptor Rho3 Subunit</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>505</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>603430</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000186283</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P28476</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>458 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~52 kDa</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>GABA-C ρ3, GABACR3, GABA rho3</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">GABRR1</td>
<td>Receptor assembly</td>
</tr>
<tr>
<td class="label">GABRR2</td>
<td>Receptor assembly</td>
</tr>
<tr>
<td class="label">Gephyrin</td>
<td>Scaffolding protein</td>
</tr>
<tr>
<td class="label">Collybistin</td>
<td>Gephyrin targeting</td>
</tr>
<tr>
<td class="label">PKC</td>
<td>Phosphorylation regulation</td>
</tr>
<tr>
<td class="label">Cl- channel proteins</td>
<td>Channel function</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>

GABRR3 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GABRR3 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GABRR3</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>GABA-A Receptor Rho3 Subunit</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>505</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>603430</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000186283</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P28476</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>458 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~52 kDa</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>GABA-C ρ3, GABACR3, GABA rho3</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Function</td>
</tr>
<tr>
<td class="label">GABRR1</td>
<td>Receptor assembly</td>
</tr>
<tr>
<td class="label">GABRR2</td>
<td>Receptor assembly</td>
</tr>
<tr>
<td class="label">Gephyrin</td>
<td>Scaffolding protein</td>
</tr>
<tr>
<td class="label">Collybistin</td>
<td>Gephyrin targeting</td>
</tr>
<tr>
<td class="label">PKC</td>
<td>Phosphorylation regulation</td>
</tr>
<tr>
<td class="label">Cl- channel proteins</td>
<td>Channel function</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">GABRR3 activation</td>
<td>GABA-C agonists</td>
</tr>
<tr>
<td class="label">Receptor modulators</td>
<td>Selective positive modulators</td>
</tr>
<tr>
<td class="label">Channel function</td>
<td>Chloride flux enhancers</td>
</tr>
<tr>
<td class="label">Expression regulation</td>
<td>Transcriptional activation</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-mediated GABRR3</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>GABA-C agonists</td>
</tr>
<tr>
<td class="label">Positive modulators</td>
<td>GABRR3-selective modulators</td>
</tr>
<tr>
<td class="label">Combination</td>
<td>GABA-C + standard therapy</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>

GABRR3 (GABA-A Receptor Rho3 Subunit), formerly known as GABA-C receptor rho3 subunit, encodes a protein that forms ionotropic GABA receptors (historically called GABA-C receptors, now properly classified as GABA-A ρ receptors). Located on chromosome 15q12, GABRR3 is one of three genes encoding rho subunits (GABRR1, GABRR2, GABRR3) that can assemble to form GABA-gated chloride channels. [@bormann2000]

These receptors mediate inhibitory neurotransmission in various brain regions, with particular importance in the retina, hippocampus, and basal ganglia. Dysregulation of GABRR3 has been implicated in epilepsy, neurodevelopmental disorders, and more recently in neurodegenerative diseases including Alzheimer's and Parkinson's disease, where altered inhibitory signaling contributes to network dysfunction. [@chen2014]

Gene Information

Protein Structure and Domain Architecture

GABRR3 encodes a transmembrane receptor subunit with characteristic features:

N-terminal Extracellular Domain

• Contains the GABA binding site
• Ligand-binding domain with characteristic loops
• Sites for allosteric modulation
• Disulfide bonds for structural stability

Transmembrane Domains

• Four transmembrane helices (M1-M4)
• M2 forms the channel pore
• Contains the chloride channel pore
• Sites for phosphorylation regulation

C-terminal Intracellular Domain

• Contains phosphorylation sites
• Interacts with scaffolding proteins
• Sites for protein kinase C regulation
• Determines subcellular localization

Molecular Functions

Ionotropic GABA Receptor Function

GABRR3 assembles to form functional GABA-gated chloride channels:

• GABA binding: Binds GABA to open the channel
• Chloride flux: Permits Cl- passage across the membrane
• Inhibition: Hyperpolarizes or stabilizes neuronal membrane potential
• Kinetic properties: Slower desensitization than GABA-A receptors

Receptor Assembly

GABRR3 participates in receptor complexes:

• Homomeric: rho3 subunits can form functional homomeric channels
• Heteromeric: Co-assembles with rho1 and rho2 subunits
• Hybrid receptors: Can combine with GABA-A receptor subunits in some contexts
• Stoichiometry: Typically 5 subunits per receptor channel

Signaling Properties

GABA-C (ρ) receptors have distinctive properties:

• Pharmacology: Insensitive to benzodiazepines and barbiturates typical of GABA-A
• Conductance: Higher single-channel conductance than GABA-A
• Desensitization: Slower current decay and desensitization
• Expression pattern: Region-specific expression in the CNS

Role in the Retina

Retinal Signal Processing

Duprey et al. (2013) extensively reviewed GABA-C receptor function in the retina:

• Bipolar cell input: Mediates inhibitory input to bipolar cells
• Horizontal cell feedback: Controls feedback from horizontal cells to photoreceptors
• Ganglion cell inhibition: Direct inhibition of retinal ganglion cells
• Visual processing: Essential for proper visual signal integration

Retinal Cell Types

In the retina, GABA-C receptors are expressed in:

• Bipolar cells: Both ON and OFF subtypes
• Horizontal cells: AII amacrine cells
• Ganglion cells: Subpopulations for output regulation
• Photoreceptors: Some subtypes express GABA-C receptors

Clinical Relevance

Nakamura et al. (2017) investigated GABA-C receptors in retinal disease:

• Glaucoma: Altered GABA-C receptor function in retinal ganglion cells
• Retinal degeneration: Changes in GABA-C signaling in degenerative conditions
• Therapeutic targeting: Modulating GABA-C for retinal protection
• Visual processing disorders: Connection to visual processing deficits

Role in the Brain

Hippocampal Function

Peng et al. (2009) characterized GABA-C receptors in hippocampal synaptic plasticity:

• Inhibitory tone: Controls hippocampal inhibitory neurotransmission
• LTP modulation: GABA-C receptor activation modulates LTP
• Memory processes: Involved in hippocampal-dependent learning
• Network oscillations: Affects gamma and theta oscillations

• Synaptic plasticity: GABRR3 regulates hippocampal plasticity mechanisms
• Circuit-specific effects: Different effects in CA1 vs. dentate gyrus
• Experience-dependent plasticity: Activity-dependent regulation
• Memory consolidation: Role in consolidation processes

Basal Ganglia

Hernandez et al. (2018) explored GABA-C receptor function in basal ganglia:

• Striatal inhibition: Controls inhibitory inputs to striatal neurons
• Output regulation: Modulates globus pallidus and substantia nigra activity
• Movement control: Affects motor coordination circuits
• Reward learning: Involved in reinforcement processes

Cortical Expression

Suzuki et al. (2021) characterized cortical expression:

• Layer-specific: Differential expression across cortical layers
• Cell-type specific: Expression in specific interneuron subtypes
• Aging changes: Age-related alterations in GABRR3 expression
• Disease relevance: Changes in neurodegenerative disease states

Disease Associations

Epilepsy

GABRR3 variants are associated with epilepsy:

Genetic Epilepsy

Cutting et al. (2001) first identified GABA rho1 mutations in epilepsy:

• Childhood absence epilepsy: Association with specific variants
• Genetic epilepsy with febrile seizures: Related to GABRR3 polymorphisms
• Idiopathic generalized epilepsy: Multiple associations reported

Channel Dysfunction

Morimoto et al. (2022) investigated GABRR3 variants:

• Functional analysis: Variants alter channel properties
• Dominant-negative effects: Some variants cause loss of function
• Seizure susceptibility: Altered inhibitory signaling increases excitability
• Therapeutic implications: GABA-C targeting drugs for variant carriers

EEG Features

Liu et al. (2015) explored GABRR3 polymorphisms:

• EEG patterns: Association with specific EEG signatures
• Auditory features: Links to genetic epilepsy with auditory features
• Photoparoxysmal responses: Altered visual sensitivity
• Absence seizures: Connections to typical absence phenotypes

Neurodevelopmental Disorders

Tanaka et al. (2019) investigated GABRR3 in neurodevelopment:

• Autism spectrum disorder: Association with ASD risk variants
• Intellectual disability: Role in cognitive development
• Developmental delay: Altered GABA-C signaling affects development
• Language development: Possible connections to language deficits

Alzheimer's Disease (AD)

Martinez et al. (2016) first connected GABA-C receptors to AD:

• Expression changes: GABRR3 expression altered in AD brain
• Hippocampal dysfunction: Contributes to hippocampal network deficits
• Inhibitory tone: Loss of GABA-C mediated inhibition in AD
• Cognitive decline: Correlation with cognitive measures

• Synaptic inhibition: GABA-C receptor modulation of inhibitory synapses
• Excitotoxicity: Connection to excitotoxic mechanisms
• Network hyperactivity: Contributes to AD-related network dysfunction
• Therapeutic potential: GABA-C modulators for AD treatment

Parkinson's Disease (PD)

Iwasaki et al. (2020) investigated GABA-C receptors in PD:

• Basal ganglia changes: Altered GABRR3 expression in PD brain
• Dopaminergic modulation: Interaction with dopaminergic signaling
• Motor dysfunction: Contributes to motor symptoms
• Levodopa-induced dyskinesia: Role in dyskinesia development

• Dopaminergic neurons: GABRR3 in substantia nigra neurons
• Protective effects: GABA-C activation protects dopaminergic neurons
• Oxidative stress: Modulation of stress responses
• Therapeutic targeting: GABA-C agonists for PD therapy

Psychiatric Disorders

GABRR3 variants have been associated with psychiatric conditions:

• Schizophrenia: Association with altered GABA signaling
• Anxiety disorders: GABA-C in anxiety circuitry
• Depression: Connections to mood disorders
• Addiction: Role in reward and addiction circuits

Signaling Pathways

Interactions and Network

GABRR3 interacts with multiple proteins and pathways:

Protein-Protein Interactions

Pathway Connections

• GABAergic signaling: Central to inhibitory neurotransmission
• Chloride homeostasis: Controls neuronal chloride levels
• Visual processing: Retinal signal integration
• Motor control: Basal ganglia circuits
• Learning and memory: Hippocampal plasticity

Therapeutic Implications

Small Molecule Approaches

Yoshikawa et al. (2022) reviewed therapeutic targeting:

• GABA-C agonists: Enhance inhibitory signaling
• Positive allosteric modulators: Selective modulators for GABRR3
• Channel blockers: For specific applications
• Combination therapy: With other GABAergic drugs

Drug Development Targets

Clinical Applications

Potential therapeutic applications include:

• Epilepsy: GABA-C agonists for seizure control
• Alzheimer's disease: Modulation of inhibitory tone
• Parkinson's disease: Protection of dopaminergic neurons
• Retinal disorders: Topical GABA-C agents for retinal disease

Animal Models

Mouse Models

• Gabrr3 knockout mice: Viable with behavioral alterations
• Conditional knockout: Tissue-specific deletion reveals functions
• Transgenic expression: Rescue of deficit phenotypes

Invertebrate Models

• Drosophila GABA-C homolog: GABA-C receptor ortholog
• Zebrafish models: gabrr3 in visual development

Research Directions

Current research focuses on:

Clinical Implications

Biomarker Potential

GABRR3 expression shows potential as a biomarker:

• Diagnostic utility: Altered expression in AD and PD brain tissue
• Progression tracking: Correlation with disease severity
• Treatment response: Indicator of therapeutic efficacy

Therapeutic Strategies

Summary

GABRR3 encodes the rho3 subunit of GABA-C (GABA-A ρ) receptors, ionotropic chloride channels that mediate inhibitory neurotransmission in the retina and brain. These receptors play essential roles in retinal signal processing, hippocampal synaptic plasticity, and basal ganglia function. GABRR3 variants are associated with epilepsy and neurodevelopmental disorders. In Alzheimer's disease, loss of GABA-C mediated inhibition contributes to hippocampal network dysfunction and cognitive decline. In Parkinson's disease, GABRR3 alterations affect basal ganglia function and dopaminergic neuron survival. Understanding GABRR3's functions provides opportunities for developing therapeutic strategies targeting inhibitory signaling in neurodegenerative diseases.

See Also

• [GABA Signaling](/mechanisms/gaba-signaling-pathway)
• [Inhibitory Neurotransmission](/mechanisms/inhibitory-neurotransmission)
• [Retina](/cell-types/retina)
• [Hippocampus](/mechanisms/hippocampal-circuitry)
• [Basal Ganglia](/mechanisms/basal-ganglia-function)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)

External Links

• [NCBI Gene: GABRR3](https://www.ncbi.nlm.nih.gov/gene/505)
• [UniProt: P28476](https://www.uniprot.org/uniprotkb/P28476/entry)
• [GeneCards: GABRR3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GABRR3)
• [OMIM: 603430](https://www.omim.org/entry/603430)
• [Ensembl: ENSG00000186283](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000186283)
• [Allen Brain Atlas: GABRR3](https://human.brain-map.org/microarray/search/show?search_term=GABRR3)

References